Question 1

What is Mettler Toledo's P/B ratio?

Accepted Answer

Mettler Toledo (MTD) P/B ratio is 1333.3× as of May 4, 2023. The ratio is calculated by dividing market capitalisation by book value of equity, using USD-normalised financials (IAS 21 exchange-rate translation for non-USD reporters).

Question 2

How is the P/B ratio calculated?

Accepted Answer

P/B = Market Capitalisation ÷ Book Value of Equity (most recent quarterly shareholders' equity), or equivalently Share Price ÷ Book Value Per Share. All inputs are sourced from audited GAAP/IFRS filings and translated to USD using period-end exchange rates so the multiple is comparable across companies and currencies.

Question 3

What is the P/B ratio?

Accepted Answer

The price-to-book (P/B) ratio compares a company's market capitalisation to its book value of equity (total shareholders' equity) on the most recent quarterly balance sheet. It is calculated as market cap ÷ book value of equity (equivalent to share price ÷ book value per share). A P/B below 1× implies the market values the business below its accounting net worth; values well above 1× reflect intangible assets, brand value, or a high return on equity.

Question 4

What is a good P/B ratio for Mettler Toledo?

Accepted Answer

A "good" P/B depends on the business model. Banks, insurers, and other capital-heavy financials typically trade near 1×; asset-light technology and consumer-brand companies can sustainably trade at 5×+ because much of their value is intangible. P/B is most informative when paired with return on equity (ROE). For Mettler Toledo specifically, the relevant sector benchmark is the current sector median of 3.2×.

Question 5

Is Mettler Toledo's P/B ratio high or low?

Accepted Answer

Mettler Toledo's P/B ratio of 1333.3× is above its own 5-year average of 972.1× and above the sector median of 3.2×. That places the current reading at the 73th percentile of its 10-year history. A higher multiple usually reflects stronger expected growth, lower perceived risk, or higher returns on capital; a lower multiple reflects the opposite.

Question 6

What is Mettler Toledo's historical P/B ratio range?

Accepted Answer

In the available daily series, Mettler Toledo (MTD) P/B ratio has ranged from a low of 2.4× in 2002 to a high of 4294.0× in 2022. The 5-year average is 972.1× and the 5-year median is 298.3×.

Question 7

What was Mettler Toledo's P/B ratio in 2022?

Accepted Answer

Mettler Toledo (MTD) P/B ratio at the end of 2022 was 1294.8×. Annual values reflect the multiple on the last trading day of each calendar year, using the trailing twelve-month book value figure available at that date.

Question 8

Why does Mettler Toledo's P/B ratio change over time?

Accepted Answer

Valuation multiples move with two inputs: the numerator (market capitalisation, which tracks the share price) and the denominator (book value). Share-price changes — driven by interest rates, earnings expectations, risk appetite, and broader market sentiment — typically dominate short-term moves, while changes in the underlying fundamental drive the longer-term trend. As a result, the ratio can rise during stock-price rallies even if the business itself has not become more valuable, and fall during sell-offs even when fundamentals are improving.


2025	$28.4B	-$23.6M	—	—	Dec 31, 2025
2024	$25.7B	-$127M	—	—	Dec 31, 2024
2023	$26.2B	-$150M	—	—	Dec 31, 2023
2022	$32.1B	$24.8M	1294.8×	+1068.0×	Dec 31, 2022
2021	$38.9B	$171M	226.8×	+131.5×	Dec 31, 2021
2020	$26.9B	$283M	95.3×	+49.6×	Dec 31, 2020
2019	$19.2B	$421M	45.7×	+21.8×	Dec 31, 2019
2018	$14.1B	$590M	23.9×	-5.0×	Dec 31, 2018
2017	$15.8B	$547M	28.9×	+3.8×	Dec 31, 2017
2016	$10.9B	$435M	25.2×	+9.4×	Dec 31, 2016
2015	$9.13B	$580M	15.7×	+3.8×	Dec 31, 2015
2014	$8.59B	$720M	11.9×	+4.3×	Dec 31, 2014
2013	$7.18B	$935M	7.7×	+0.5×	Dec 31, 2013
2012	$5.9B	$827M	7.1×	+1.2×	Dec 31, 2012
2011	$4.66B	$781M	6.0×	-0.4×	Dec 31, 2011
2010	$4.88B	$772M	6.3×	+1.3×	Dec 31, 2010
2009	$3.54B	$711M	5.0×	+0.5×	Dec 31, 2009
2008	$2.26B	$503M	4.5×	-2.4×	Dec 31, 2008
2007	$4B	$581M	6.9×	+2.1×	Dec 31, 2007
2006	$3B	$631M	4.8×	+1.3×	Dec 31, 2006
2005	$2.27B	$659M	3.4×	+0.4×	Dec 31, 2005
2004	$2.21B	$721M	3.1×	+0.2×	Dec 31, 2004
2003	$1.88B	$654M	2.9×	+0.0×	Dec 31, 2003
2002	$1.42B	$502M	2.8×	—	Dec 31, 2002


Charles River (CRL)	2.6×
Danaher (DHR)	2.6×
Spruce Biosciences (SPRB)	2.6×
Regeneron Pharmaceuticals (REGN)	2.6×
Henry Schein (HSIC)	2.5×
Labcorp Holdings (LH)	2.5×
Solventum (SOLV)	2.3×
Medtronic (MDT)	2.2×
Elevance Health (ELV)	1.9×
Becton, Dickinson and (BDX)	1.8×
Pfizer (PFE)	1.8×
Cigna (CI)	1.7×
Waters Corporation (WAT)	1.6×
Cooper Companies (COO)	1.5×
Universal Health Services (UHS)	1.5×
Biogen (BIIB)	1.4×
Baxter International (BAX)	1.4×
Zimmer Biomet Holdings (ZBH)	1.4×
Revvity (RVTY)	1.4×
CVS Health (CVS)	1.2×
Humana (HUM)	1.1×
Viatris (VTRS)	1.1×
Ovid Therapeutics (OVID)	0.8×
Centene (CNC)	0.8×
Teladoc Health (TDOC)	0.7×

P/B Ratio for Mettler Toledo (MTD) 2002-2026

P/B Ratio daily chart for Mettler Toledo (MTD)

Historical P/B Ratio for Mettler Toledo (MTD) from 2002 to 2025

About P/B Ratio at Mettler Toledo (MTD)

Mettler Toledo P/B Ratio by Year

Mettler Toledo P/B Ratio 2022: 1294.8×

Mettler Toledo P/B Ratio 2021: 226.8×

Mettler Toledo P/B Ratio 2020: 95.3×

Mettler Toledo P/B Ratio 2019: 45.7×

Mettler Toledo P/B Ratio 2018: 23.9×

Sector peers by P/B Ratio — chart

Sector peers by P/B Ratio — table

Frequently asked questions

Mettler Toledo (MTD) Key Financials